Clinical Trial Update: Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects [Phase 1]

View source ↗

Summary

Phase 1 randomized study comparing APRISO 375 mg with the approved APRISO 375 mg capsules in healthy volunteers to evaluate pharmacokinetic equivalence between …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• APRISO 375 mg (mesalamine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED